These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 16703122

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 5. [The newer sedative-hypnotics].
    Sukys-Claudino L, Moraes WA, Tufik S, Poyares D.
    Braz J Psychiatry; 2010 Sep; 32(3):288-93. PubMed ID: 20945020
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and clinical safety of ramelteon: an evidence-based review.
    Sateia MJ, Kirby-Long P, Taylor JL.
    Sleep Med Rev; 2008 Aug; 12(4):319-32. PubMed ID: 18603221
    [Abstract] [Full Text] [Related]

  • 7. Fresh from the pipeline: Ramelteon.
    Buysse D, Bate G, Kirkpatrick P.
    Nat Rev Drug Discov; 2005 Nov; 4(11):881-2. PubMed ID: 16299918
    [No Abstract] [Full Text] [Related]

  • 8. [New hypnotics ramelteon for the treatment of insomniacs with circadian rhythm disturbance].
    Mishima K.
    Nihon Rinsho; 2012 Jun; 70(6):1069-78. PubMed ID: 22690618
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy.
    Spadoni G, Bedini A, Lucarini S, Mor M, Rivara S.
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1145-56. PubMed ID: 25956235
    [Abstract] [Full Text] [Related]

  • 10. Ramelteon 8 mg/d versus placebo in patients with chronic insomnia: post hoc analysis of a 5-week trial using 50% or greater reduction in latency to persistent sleep as a measure of treatment effect.
    Mini L, Wang-Weigand S, Zhang J.
    Clin Ther; 2008 Jul; 30(7):1316-23. PubMed ID: 18691991
    [Abstract] [Full Text] [Related]

  • 11. Ramelteon: TAK 375.
    Drugs R D; 2005 Jul; 6(3):186-8. PubMed ID: 15869323
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology of ramelteon, a selective MT1/MT2 receptor agonist: a novel therapeutic drug for sleep disorders.
    Miyamoto M.
    CNS Neurosci Ther; 2009 Jul; 15(1):32-51. PubMed ID: 19228178
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological characterization of M-II, the major human metabolite of ramelteon.
    Nishiyama K, Nishikawa H, Kato K, Miyamoto M, Tsukamoto T, Hirai K.
    Pharmacology; 2014 Jul; 93(3-4):197-201. PubMed ID: 24923230
    [Abstract] [Full Text] [Related]

  • 14. Ramelteon: a novel approach in the treatment of insomnia.
    Reynoldson JN, Elliott E, Nelson LA.
    Ann Pharmacother; 2008 Sep; 42(9):1262-71. PubMed ID: 18648020
    [Abstract] [Full Text] [Related]

  • 15. Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist.
    Kato K, Hirai K, Nishiyama K, Uchikawa O, Fukatsu K, Ohkawa S, Kawamata Y, Hinuma S, Miyamoto M.
    Neuropharmacology; 2005 Feb; 48(2):301-10. PubMed ID: 15695169
    [Abstract] [Full Text] [Related]

  • 16. [Melatonin agonist causes amplitude increase of the internal clock: for a productive day after a good night].
    MMW Fortschr Med; 2009 Mar 26; 151(13):85. PubMed ID: 19504828
    [No Abstract] [Full Text] [Related]

  • 17. Ramelteon for the treatment of insomnia.
    Borja NL, Daniel KL.
    Clin Ther; 2006 Oct 26; 28(10):1540-55. PubMed ID: 17157111
    [Abstract] [Full Text] [Related]

  • 18. Ramelteon: a review of its use in insomnia.
    Simpson D, Curran MP.
    Drugs; 2008 Oct 26; 68(13):1901-19. PubMed ID: 18729542
    [Abstract] [Full Text] [Related]

  • 19. [Recent and potential drugs for treatment of insomnia].
    Terao A, Miyamoto M.
    Nihon Yakurigaku Zasshi; 2007 Jan 26; 129(1):35-41. PubMed ID: 17220574
    [No Abstract] [Full Text] [Related]

  • 20. Ramelteon: application withdrawn. Ramelteon in insomnia: withdrawal of marketing application in patients' best interests.
    Prescrire Int; 2009 Jun 26; 18(101):114. PubMed ID: 19639675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.